Skip to content
lifestyle.jardal-paintball.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Ovid Therapeutics Inc.
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
July 8, 2026
Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14
April 8, 2026
Ovid Therapeutics Announces Pricing of $60 Million Private Placement
March 18, 2026
Ovid Therapeutics to Participate in Upcoming Investor Conferences
February 25, 2026